InSilicoTrials With The Jackson Laboratory Lead CARDIOVERSE, a $30M Initiative Funded by ARPA-H to Redefine Cardiac Drug Safety with Virtual Heart Models

InSilicoTrials joins The Jackson Laboratory, UConn Health, and the University of Michigan in leading CARDIOVERSE, an ARPA-H-funded initiative of up to $30M to advance AI-powered virtual heart models for safer drug development.